Plain-English translation of NCT07143149 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smart computer system can help doctors and patients do a better job managing cholesterol after a stroke or mini-stroke. You'll be taking a medication called Evolocumab, which lowers cholesterol, and the study is checking whether having personalized guidance from this intelligent system helps you reach your cholesterol targets within one year.
Studies show that lowering cholesterol after a stroke prevents future strokes, but many patients don't reach their cholesterol goals or don't stick with their medications. This trial wants to see if a system that gives doctors better guidance and reminds patients to take their medication can help more people succeed.
You likely qualify if…
You likely don't qualify if…
If you are in the intervention group, you'll receive personalized cholesterol guidance and reminders through a digital system — your doctor will get treatment recommendations based on your test results, and you'll get regular reminders to check your cholesterol and take your medication. If you are in the usual care group, you'll receive standard stroke follow-up care. Either way, the study will track how well you reach your cholesterol target over 12 months and may ask you to share cholesterol test results.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China